Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015;7(16):2041-56.
doi: 10.4155/bio.15.127.

Cocaine and metabolite concentrations in DBS and venous blood after controlled intravenous cocaine administration

Kayla N Ellefsen  1   2 , Jose Luiz da Costa  1   3 , Marta Concheiro  4 , Sebastien Anizan  1 , Allan J Barnes  1 , Sandrine Pirard  1 , David A Gorelick  5 , Marilyn A Huestis  1
Affiliations

Cocaine and metabolite concentrations in DBS and venous blood after controlled intravenous cocaine administration

Kayla N Ellefsen et al. Bioanalysis. 2015.

Abstract

Background: DBS are an increasingly common clinical matrix.

Methods & results: Sensitive and specific methods for DBS and venous blood cocaine and metabolite detection by LC-HRMS and 2D GC-MS, respectively, were validated to examine correlation between concentrations following controlled intravenous cocaine administration. Linear ranges from 1 to 200 µg/l were achieved, with acceptable bias and imprecision. Authentic matched specimens' (392 DBS, 97 venous blood) cocaine and benzoylecgonine concentrations were qualitatively similar, but DBS had much greater variability (21.4-105.9 %CV) and were lower than in blood.

Conclusion: DBS offer advantages for monitoring cocaine intake; however, differences between capillary and venous blood and DBS concentration variability must be addressed.

PubMed Disclaimer

Conflict of interest statement

Financial & competing interests disclosure This work was supported by the Intramural Research Program (IRP), National Institute on Drug Abuse (NIDA), NIH. JL da Costa received a postdoctoral fellowship from Brazilian National Counsel of Technological and Scientific Development (CNPq) to conduct this research. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.

Figures

<b>Figure 1.</b>
Figure 1.. Cocaine and benzoylecgonine in DBS and matched blood samples from participant L, 60 min after 25 mg intravenous cocaine.
(A) LC–MS/MS chromatogram of DBS specimen with 42.9 µg/l cocaine and 78.5 µg/l BE. Norcocaine was not detected. (B) Corresponding venous blood 2D GC–MS chromatogram with 40.7 µg/l cocaine and 107.4 µg/l BE. BE: Benzoylecgonine.
<b>Figure 2.</b>
Figure 2.. Median cocaine and benzoylecgonine concentrations in DBS and venous blood from 13 participants 30, 60 and 90 min following 25 mg/kg intravenous cocaine administrations on three separate days (days 1, 5 and 10).
Error bars represent one standard deviation constrained to 0. BE: Benzoylecgonine.
<b>Figure 3.</b>
Figure 3.. Comparison between venous blood and DBS cocaine and benzoylecgonine concentrations in simultaneously collected specimens from 13 participants 30, 60 and 90 min following 25 mg/kg intravenous cocaine administration on three separate days (days 1, 5 and 10).
Only paired venous blood-DBS specimens within the linear range were included in correlations and Bland-Altman analysis plots: cocaine (n = 87) and benzoylecgonine (BE) (n = 90). (A) Correlation of venous blood with median DBS cocaine and BE concentrations. Regression was calculated by least-squares regression analysis. (B) Bland-Altman analysis plots comparing blood and DBS collection methods for cocaine and BE detection. Dotted lines represent the 95% limits of agreement (mean difference ± 2SD).
See this image and copyright information in PMC

References

    1. United Nations Office on Drugs and Crime (UNODC) World Drug Report 2014. Vienna, Austria: 2014. www.unodc.org/documents/data-and-analysis/WDR2014/World_Drug_Report_2014...
    1. U.S. Drug Enforcement Administration (DEA) National Forensic Laboratory Information System: 2013 Annual Report. Springfiled, Virginia: 2014. www.nflis.deadiversion.usdoj.gov/DesktopModules/ReportDownloads/Reports/...
    1. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Annual Report 2012: The State of the Drugs Problem in Europe. Lisbon, Portugal: 2012. www.emcdda.europa.eu/publications/annual-report/2012
    1. Substance Abuse and Mental Health Services Administration (SAMHSA) Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings. Rockville, Maryland: 2013. www.samhsa.gov/data/sites/default/files/NSDUHresults2012/NSDUHresults201...
    1. Jatlow P. Cocaine: analysis, pharmacokinetics, and metabolic disposition. Yale J. Biol. Med. 1988;61:105–113. - PMC - PubMed

Publication types

LinkOut - more resources